• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用预混膜乳化法制备乳铁蛋白修饰的 mPEG-PLA 纳米粒经鼻递送至脑内的 α-细辛脑

Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification.

机构信息

Separation Engineering of Chinese Traditional Medicine Compound, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.

Department of Pharmaceutical Analysis, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People's Republic of China.

出版信息

Drug Deliv Transl Res. 2018 Feb;8(1):83-96. doi: 10.1007/s13346-017-0438-8.

DOI:10.1007/s13346-017-0438-8
PMID:29134552
Abstract

Alpha-asarone is a bioactive component of Acorus tatarincuii Schott with low bioavailability, which is often used for treatments of various brain diseases in clinical setting. This study was to formulate biodegradable methoxy polyethylene glycol-polylactic acid (mPEG-PLA) nanoparticles (NPs) surface-modified by lactoferrin (Lf), for delivering α-asarone into the brain following intranasal administration. Alpha-asarone NPs were prepared by premix membrane emulsification. The relative parameters were optimized by a Box-Behnken experimental design. The particle size, zeta potential, and dispersibility index of NPs and Lf-NPs were characterized. Their ex vivo permeation, pharmacokinetics, distribution in the brain and other tissue, brain targeting, and toxicity were investigated. Following intranasal administration, Lf-NPs had a better permeability and no significant poor bioavailability compared to NPs; the area under curve from 0 to 12 h of α-asarone in Lf-NPs of the olfactory bulb, hippocampus, olfactory bundles, and thalamus were 2.14-, 4.17-, 3.62-, and 1.96-fold of those in NP group, respectively. Lactoferrin could enhance the efficacy of brain targeting with NPs and reduce its liver accumulation. Toxicity of NPs on nasal mucosal cilia and epithelial cells was also decreased by Lf. To summarize, these results demonstrate that Lf-NPs of α-asarone have potential as a carrier for nose-to-brain delivery of α-asarone for brain diseases.

摘要

α-细辛脑是菖蒲的一种生物活性成分,生物利用度低,常用于临床治疗各种脑部疾病。本研究旨在通过表面修饰乳铁蛋白(Lf),制备可生物降解的甲氧基聚乙二醇-聚乳酸(mPEG-PLA)纳米粒(NPs),用于经鼻给药后将 α-细辛脑递送至脑部。采用预混膜乳化法制备 α-细辛脑 NPs,采用 Box-Behnken 实验设计优化相对参数。对 NPs 和 Lf-NPs 的粒径、Zeta 电位和分散指数进行了表征。考察了它们的体外渗透、药代动力学、在脑及其他组织中的分布、脑靶向性和毒性。经鼻给药后,Lf-NPs 与 NPs 相比具有更好的渗透性,没有明显的生物利用度降低;Lf-NPs 组嗅球、海马、嗅束和丘脑的 α-细辛脑的 AUC0-12h 分别为 NP 组的 2.14、4.17、3.62 和 1.96 倍。Lf 可增强 NPs 的脑靶向作用,并减少其在肝脏中的蓄积。Lf 还降低了 NPs 对鼻黏膜纤毛和上皮细胞的毒性。综上所述,这些结果表明,Lf-NPs 载 α-细辛脑具有作为治疗脑部疾病的经鼻递药载体的潜力。

相似文献

1
Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification.采用预混膜乳化法制备乳铁蛋白修饰的 mPEG-PLA 纳米粒经鼻递送至脑内的 α-细辛脑
Drug Deliv Transl Res. 2018 Feb;8(1):83-96. doi: 10.1007/s13346-017-0438-8.
2
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.用乳铁蛋白修饰的聚乙二醇-聚乳酸-羟基乙酸共聚物纳米颗粒经鼻给药将罗替戈汀输送至大脑用于帕金森病治疗
Int J Nanomedicine. 2016 Dec 7;11:6547-6559. doi: 10.2147/IJN.S120939. eCollection 2016.
3
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.使用乳铁蛋白共轭的N-三甲基化壳聚糖表面修饰的聚乳酸-羟基乙酸共聚物纳米颗粒经鼻向脑递送石杉碱甲用于治疗阿尔茨海默病。
Int J Nanomedicine. 2018 Feb 1;13:705-718. doi: 10.2147/IJN.S151474. eCollection 2018.
4
[Pharmacokinetics of α-asarone after intranasal and intravenous administration with PLA-α-asarone nanoparticles].[聚乳酸-α-细辛醚纳米粒经鼻内和静脉给药后α-细辛醚的药代动力学]
Zhongguo Zhong Yao Za Zhi. 2017 Jun;42(12):2366-2372. doi: 10.19540/j.cnki.cjcmm.20170307.009.
5
[Preparation and release behaviour of mPEG-PLA α-asarone nanoparticles designed for nasal administration].用于鼻腔给药的甲氧基聚乙二醇-聚乳酸-α-细辛脑纳米粒的制备及其释放行为
Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(24):4847-52.
6
Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.乳铁蛋白修饰的聚乙二醇接枝牛血清白蛋白纳米粒作为治疗脑胶质瘤的双靶向载体
Mol Pharm. 2014 Jun 2;11(6):1823-34. doi: 10.1021/mp500238m. Epub 2014 May 15.
7
The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.大鼠经鼻腔应用聚乙二醇-聚乳酸纳米粒后的脑靶向效率
J Drug Target. 2006 Jun;14(5):281-90. doi: 10.1080/10611860600721051.
8
Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.乳铁蛋白修饰的 PEG-co-PCL 纳米粒经鼻内给药后增强 NAP 肽脑内递释
Biomaterials. 2013 May;34(15):3870-81. doi: 10.1016/j.biomaterials.2013.02.003. Epub 2013 Feb 27.
9
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.具有改善脑递送能力的乳铁蛋白共轭聚乙二醇-聚乳酸纳米颗粒:体外和体内评估
J Control Release. 2009 Feb 20;134(1):55-61. doi: 10.1016/j.jconrel.2008.10.016. Epub 2008 Nov 12.
10
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.乳铁蛋白负载 hupA 纳米乳经鼻给药靶向药物传输的优化设计。
Int J Nanomedicine. 2019 Nov 27;14:9217-9234. doi: 10.2147/IJN.S214657. eCollection 2019.

引用本文的文献

1
Volatile oil of : potential candidate drugs for mitigating dementia.挥发油:缓解痴呆症的潜在候选药物。
Front Pharmacol. 2025 Apr 23;16:1552801. doi: 10.3389/fphar.2025.1552801. eCollection 2025.
2
Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration.纳米技术在脑治疗中关于基因靶向和鼻脑给药的前景。
iScience. 2023 Jul 16;26(8):107321. doi: 10.1016/j.isci.2023.107321. eCollection 2023 Aug 18.
3
Lactoferrin as a Component of Pharmaceutical Preparations: An Experimental Focus.

本文引用的文献

1
Sleep promoting potential of low dose α-Asarone in rat model.低剂量α-细辛脑在大鼠模型中的促眠潜力。
Neuropharmacology. 2017 Oct;125:13-29. doi: 10.1016/j.neuropharm.2017.07.003. Epub 2017 Jul 8.
2
Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.经鼻给予阿戈美拉汀固体脂质纳米粒以增强脑内递送:制剂、优化及体内药代动力学
Drug Des Devel Ther. 2017 Jun 19;11:1815-1825. doi: 10.2147/DDDT.S102500. eCollection 2017.
3
Asarone from Acori Tatarinowii Rhizome prevents oxidative stress-induced cell injury in cultured astrocytes: A signaling triggered by Akt activation.
乳铁蛋白作为药物制剂的一种成分:实验重点
Pharmaceuticals (Basel). 2023 Jan 31;16(2):214. doi: 10.3390/ph16020214.
4
Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders.通过鼻脑递送来治疗神经紊乱的生物共轭纳米药物的最新趋势。
Drug Deliv Transl Res. 2022 Dec;12(12):3104-3120. doi: 10.1007/s13346-022-01173-y. Epub 2022 May 15.
5
Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders.α-细辛醚和β-细辛醚治疗神经疾病的分子机制及治疗潜力
Antioxidants (Basel). 2022 Jan 29;11(2):281. doi: 10.3390/antiox11020281.
6
Using nanotechnology to deliver biomolecules from nose to brain - peptides, proteins, monoclonal antibodies and RNA.利用纳米技术将生物分子从鼻腔递送到大脑 - 肽、蛋白质、单克隆抗体和 RNA。
Drug Deliv Transl Res. 2022 Apr;12(4):862-880. doi: 10.1007/s13346-021-01086-2. Epub 2021 Nov 3.
7
Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.天然植物化学物质作为预防和治疗帕金森病的新型治疗策略:当前知识和未来展望。
Oxid Med Cell Longev. 2021 May 25;2021:6680935. doi: 10.1155/2021/6680935. eCollection 2021.
8
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics.用于脑部疾病诊断、治疗及诊疗一体化的多功能聚合物纳米平台
Biomedicines. 2020 Jan 13;8(1):13. doi: 10.3390/biomedicines8010013.
9
Preparation, In Vivo and In Vitro Release of Polyethylene Glycol Monomethyl Ether-Polymandelic Acid Microspheres Loaded .聚乙二醇单甲醚-聚乳清酸微球的制备、体内外释放。
Molecules. 2019 May 27;24(10):2024. doi: 10.3390/molecules24102024.
10
Morphological evaluation using MRI of the olfactory filaments (fila) in a post-traumatic olfactory rat model.在创伤后嗅觉大鼠模型中使用磁共振成像(MRI)对嗅丝进行形态学评估。
World J Otorhinolaryngol Head Neck Surg. 2018 May 11;4(1):50-56. doi: 10.1016/j.wjorl.2018.03.004. eCollection 2018 Mar.
石菖蒲中的细辛醚可预防氧化应激诱导的培养星形胶质细胞损伤:由Akt激活触发的信号传导。
PLoS One. 2017 Jun 9;12(6):e0179077. doi: 10.1371/journal.pone.0179077. eCollection 2017.
4
The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.透明质酸作为药物载体提高缓释眼用制剂生物利用度的作用。以透明质酸-噻吗洛尔离子复合物为例。
Eur J Pharm Sci. 2017 Jul 15;105:188-194. doi: 10.1016/j.ejps.2017.05.020. Epub 2017 May 12.
5
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.用乳铁蛋白修饰的聚乙二醇-聚乳酸-羟基乙酸共聚物纳米颗粒经鼻给药将罗替戈汀输送至大脑用于帕金森病治疗
Int J Nanomedicine. 2016 Dec 7;11:6547-6559. doi: 10.2147/IJN.S120939. eCollection 2016.
6
Influence of surface passivation of 2-Methoxyestradiol loaded PLGA nanoparticles on cellular interactions, pharmacokinetics and tumour accumulation.负载2-甲氧基雌二醇的聚乳酸-羟基乙酸共聚物纳米粒的表面钝化对细胞相互作用、药代动力学及肿瘤蓄积的影响
Colloids Surf B Biointerfaces. 2017 Feb 1;150:242-249. doi: 10.1016/j.colsurfb.2016.11.040. Epub 2016 Nov 29.
7
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.载有生物粘附性壳聚糖的脂质体:一种用于马来酸噻吗洛尔的更高效、更高渗透性的眼部给药平台。
Int J Biol Macromol. 2017 Jan;94(Pt A):355-363. doi: 10.1016/j.ijbiomac.2016.10.035. Epub 2016 Oct 17.
8
[Preparation and release behaviour of mPEG-PLA α-asarone nanoparticles designed for nasal administration].用于鼻腔给药的甲氧基聚乙二醇-聚乳酸-α-细辛脑纳米粒的制备及其释放行为
Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(24):4847-52.
9
Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.新兴的转化药代动力学和药代动力学-药效学研究见解:迈向人类鼻脑转运的预测。
AAPS J. 2015 May;17(3):493-505. doi: 10.1208/s12248-015-9724-x. Epub 2015 Feb 19.
10
Distribution of α-asarone in brain following three different routes of administration in rats.大鼠三种不同给药途径后α-细辛脑在脑中的分布。
Eur J Pharm Sci. 2014 Oct 15;63:63-70. doi: 10.1016/j.ejps.2014.06.006. Epub 2014 Jul 5.